Clinical Trial Update: Colorectal Cancer Treated With Adjuvant Regorafenib Versus Placebo After Curative Treatment of Liver Metastases in a Randomized, Double-blind, Placebo-Controlled Phase-III STudy [Phase 3]

View source ↗

Summary

A phase 3 randomized, double-blind trial evaluating adjuvant regorafenib versus placebo after curative treatment of liver metastases in colorectal cancer was te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Stivarga (regorafenib)

Snippet

Sponsor: Bayer | Conditions: Colorectal Neoplasms | Phase 3 | Status: TERMINATED | Results posted: 2017-10-20